M2 macrophages are significantly increased in the BM of patients with MM relative to patients with MGUS, patients with SMM, and healthy donors; this effect appears to be largely mediated by increased levels of CXCL12 and IL-10 in the tumor microenvironment. This evidence concerns the gene IL10 and Miyoshi myopathy.